FI20085973A - Menetelmä solujen suojaamiseksi - Google Patents

Menetelmä solujen suojaamiseksi Download PDF

Info

Publication number
FI20085973A
FI20085973A FI20085973A FI20085973A FI20085973A FI 20085973 A FI20085973 A FI 20085973A FI 20085973 A FI20085973 A FI 20085973A FI 20085973 A FI20085973 A FI 20085973A FI 20085973 A FI20085973 A FI 20085973A
Authority
FI
Finland
Prior art keywords
protecting cells
protecting
cells
Prior art date
Application number
FI20085973A
Other languages
English (en)
Swedish (sv)
Other versions
FI121073B (fi
FI20085973A0 (fi
Inventor
Taina Jaatinen
Seppo Meri
Sami Junnikkala
Jarmo Laine
Jukka Partanen
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI20085973A priority Critical patent/FI121073B/fi
Publication of FI20085973A0 publication Critical patent/FI20085973A0/fi
Priority to US13/123,818 priority patent/US20110217724A1/en
Priority to PCT/FI2009/050833 priority patent/WO2010043772A2/en
Priority to CA2740762A priority patent/CA2740762A1/en
Priority to EP09759743A priority patent/EP2358354A2/en
Priority to AU2009305331A priority patent/AU2009305331B2/en
Publication of FI20085973A publication Critical patent/FI20085973A/fi
Application granted granted Critical
Publication of FI121073B publication Critical patent/FI121073B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI20085973A 2008-10-15 2008-10-15 Menetelmä solujen suojaamiseksi FI121073B (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20085973A FI121073B (fi) 2008-10-15 2008-10-15 Menetelmä solujen suojaamiseksi
US13/123,818 US20110217724A1 (en) 2008-10-15 2009-10-15 Method of protecting cells
PCT/FI2009/050833 WO2010043772A2 (en) 2008-10-15 2009-10-15 Method of protecting cells
CA2740762A CA2740762A1 (en) 2008-10-15 2009-10-15 Method of protecting cells
EP09759743A EP2358354A2 (en) 2008-10-15 2009-10-15 Method of protecting cells
AU2009305331A AU2009305331B2 (en) 2008-10-15 2009-10-15 Method of protecting cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20085973A FI121073B (fi) 2008-10-15 2008-10-15 Menetelmä solujen suojaamiseksi
FI20085973 2008-10-15

Publications (3)

Publication Number Publication Date
FI20085973A0 FI20085973A0 (fi) 2008-10-15
FI20085973A true FI20085973A (fi) 2010-04-16
FI121073B FI121073B (fi) 2010-06-30

Family

ID=39924616

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20085973A FI121073B (fi) 2008-10-15 2008-10-15 Menetelmä solujen suojaamiseksi

Country Status (5)

Country Link
US (1) US20110217724A1 (fi)
EP (1) EP2358354A2 (fi)
CA (1) CA2740762A1 (fi)
FI (1) FI121073B (fi)
WO (1) WO2010043772A2 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014206414A1 (en) * 2013-06-28 2014-12-31 Region Syddanmark Complement factor h for use in the treatment of bone diseases
US20200325449A1 (en) * 2016-06-02 2020-10-15 The Cleveland Clinic Foundation Complement inhibition for improving cell viability
US20210353685A1 (en) * 2020-05-14 2021-11-18 Brain Cancer Research Institute Augmentation of Cell Therapy Efficacy by Inhibition of Complement Activation Pathways

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679345A (en) * 1994-06-02 1997-10-21 The Johns Hopkins University Method for preventing complement-dependent rejection of organ or tissue transplants
AU2004229171B2 (en) * 2003-04-16 2007-10-25 Novartis Ag Vav inhibition in graft rejection
WO2007016099A2 (en) * 2005-07-29 2007-02-08 Musc Foundation For Research Development Protection of transplanted stem cells with hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
FI121073B (fi) 2010-06-30
WO2010043772A8 (en) 2010-06-10
EP2358354A2 (en) 2011-08-24
FI20085973A0 (fi) 2008-10-15
US20110217724A1 (en) 2011-09-08
CA2740762A1 (en) 2010-04-22
AU2009305331A1 (en) 2010-04-22
WO2010043772A3 (en) 2011-02-24
WO2010043772A2 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
BRPI0919116A2 (pt) método
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
IT1393131B1 (it) Controvento a ingobbamento limitato
EP2378719A4 (en) METHOD FOR IMPLEMENTING RAPID REROUTING
HK1141251A1 (en) A method for enhancing cell response
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
DK2313489T3 (da) Fremstillingsmetode
FI20085275L (fi) Menetelmä biomassan käsittelemiseksi
BRPI1010705A2 (pt) método
BRPI0911359A2 (pt) híbridos polímero - dendrímero
DE602008004490D1 (de) Werkzeugwechselsystem
BRPI1012532A2 (pt) método
FI20085564A (fi) Menetelmä puun suojaamiseksi
BRPI0916597A2 (pt) Método
DK2138386T3 (da) Holdeindretning til en rangeringsindretning
BRPI1009350A2 (pt) método
FR2955767B1 (fr) Composition destinee a la protection solaire
FI20085973A (fi) Menetelmä solujen suojaamiseksi
IT1394172B1 (it) Metodo prognostico
FI20086031A0 (fi) Valkaisumenetelmä
PT2358215E (pt) Método de protecção de substâncias ativas utilizando glicerol
IT1392231B1 (it) Metodo di gestione

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 121073

Country of ref document: FI

MM Patent lapsed